The haemodynamic effects of large bolus doses of metocurine 0.45 mg kg" 1 and pancuronium 0.1 mg kg" 1 were compared in patients with coronary artery disease anaesthetized with diazepam, anileridine and nitrous oxide. Hypotension occurred more frequently after metocurine and was a result of a decrease in systemic vascular resistance. After pancuronium there was no increase in arterial pressure or heart rate, but a small increase in cardiac index. The decrease in heart rate after metocurine was the principal cause of the statistically significant difference in cardiac index between the two groups. Contrary to previous findings, metocurine did not attenuate circulatory responses to tracheal intubation. During surgical stimulation, two of the 10 patients of the pancuronium group developed significant ST segment depression and three patients had a rate-pressure product greater than 12 000 mm Hg beat min" 1 . However, the difference in rate-pressure product between the groups was not statistically significant.
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Anaesthesia and plan of investigation
On the evening before operation the patients were given one to two tablets, each containing pentobarbitone 100 mg and promethazine 25 mg,,and 1 h before arrival at the operating theatre, diazepam <£) Macmillan Publishers Ltd 1980 0.2 mg kg" 1 was given orally. On arrival an i.v. infusion of 5% glucose solution was commenced and diazepam 0.1 mg kg" 1 given i.v. Intravascular catheters were inserted under local anaesthesia (1% lignocaine) and the patient was allowed to rest for a few minutes. Control measurements of cardiac output and intravascular pressures were made and blood samples were obtained for analyses of blood-gas tensions, acid-base balance and haemoglobin concentration while the patient was breathing room air.
Anaesthesia was induced with diazepam 0.3 mg kg" 1 , followed by anileridine 0.4 mg kg" 1 (Leritine: Merck, Sharp & Dohme) and thiopentone 1 mg kg"
1 . The injection rate of diazepam was 5 mg min" 1 and that of anileridine 10 mg min" 1 , whereas thiopentone was administered within 1 min (Anileridine is approximately four times as potent as pethidine with minimal cardiovascular effects in unanaesthetized patients (Tuominen, Heinonen and Heikkila, 1976) .) From the start of induction, the patients breathed a mixture of 60% nitrous oxide in oxygen via a facemask and a non-rebreathing valve and, when needed, ventilation was assisted or controlled manually After a second series of measurements, one of the test drugs was given in double-blind fashion. Pancuronium (Pavulon, Organon) 0.1 mg kg" 1 or metocurine (Metubine iodide, Lilly) 0.45 mg kg" 1 was injected rapidly into a peripheral vein and a third set of measurements was made 5 min after the injection. Thereafter, the larynx and trachea were sprayed with 4% lignocaine 3 ml, endotracheal intubation was performed and the patient's lungs were ventilated using an Engstrom respirator (model 200) . At this stage the fourth set of measurements was made.
Artificial ventilation with a 60% nitrous oxide in oxygen mixture was performed at a frequency of 16 b.p.m. In our experience, ventilation with the minute volume derived from the Engstrom-Herzog nomogram usually produces hypocapnia and so ventilation was performed with a minute volume 10% smaller than that indicated by the nomogram. After endotracheal intubation a further dose of anileridine was given (1.6 mg kg" 1 ,10 mg min" 1 ). The degree of neuromuscular block was estimated according to the train-of-four principle, using 2 Hz supramaximal stimulation (Wakeling Instruments Ltd) of the iilnar nerve (Lee, 1975) . The aim was to maintain a block of at least 80-90%.
A fifth series of measurements was made immediately before surgery commenced and a sixth after sternotomy.
Techniques of measurement
A Swan-Ganz flow-directed thermodilution catheter size 7 F (Edwards Laboratories) was inserted via the right internal jugular vein and its tip was positioned in a branch of the pulmonary artery under pressure and e.c.g. monitoring. This was used for measurement of pulmonary arterial pressure (p.a.p.), pulmonary capillary wedge pressure (p.c.w.p.) and central venous pressure (c.v.p.) and sampling of mixed venous blood. A cannula was inserted to the radial artery for arterial blood sampling and measurement of systemic arterial pressure (AP). The catheters were connected to appropriate transducers and pressures were recorded with an ink-jet recorder (Mingograf 81, Elema-Schonander). The zero reference point was taken as 5 cm posterior to the sternal angle and intravascular pressures were recorded at end-expiration. Leads V B and aVF of the e.c.g. were monitored continuously and recorded during the periods of measurement. Cardiac output (CO) was measured using the Swan-Ganz thermodilution catheter and Devices cardiac output computer 3750 (Branthwaite and Bradley, 1968; AaltoSetSla, Heinonen and Salorinne, 1975) .
The blood samples were drawn into heparinized glass syringes and immersed in ice water until analysed. Po v pH and Pco 2 were measured and base excess (BE) was derived by an automatic analyser (ABL 1, Radiometer). Corrections for temperature were made, using the nomograms of Relman and Nunn (1966) , if the rectal temperature of the patient was less than 36.5 °C.
Calculations
Systemic vascular resistance (SVR) was calculated as follows: m.a.p. -c.v.p.
SVR. CO
Rate-pressure product (RPP) was calculated by multiplication of the heart rate by systolic arterial pressure; oxygen consumption was derived from CO x arterial-mixed venous oxygen content difference. Blood Qxyhaemoglobin saturation was derived from the dissociation curve line charts of Kelman and Nunn (1966) .
Statistical analysis
The paired t test was used when the statistical significance of changes within a group was analysed. This test was applied only when the immediate haemodynamic effects of the neuromuscular blocking drugs were studied (stage 3 as compared with stage 2).
The t test for two independent samples was used for analysis of the statistical significance between the changes within the two groups. The difference was considered significant when P<0.05.
RESULTS
Before induction of anaesthesia (stage 1) there was a statistically significant difference in stroke index (SI) and SVR between the two groups (table II). These differences disappeared after induction (stage 2) when a significant difference in c.v.p. was noted. Figure 1 shows the changes from the haemodynamic values after induction in stages 3-6 of the study. After metocurine (stage 3), there was a significant decrease in m.a.p., m.p.a.p., p.c.w.p., c.v.p., RPP (P<0.01), HR and SVR (P<0.05). The decrease in m.a.p. can be attributed to the decrease in SVR. After pancuronium, a small but statistically significant increase in CI (P<0.05) was found and the small decreases in m.p.a.p., p.c.w.p. (P<0.05) and c.v.p. (P<0.01) were also statistically significant. When the differences between the changes within the two groups were analysed, the only significant difference was that in CI (P<0.05). The decrease in HR in the metocurine group was the principal cause of this difference. In stage 3, a decrease in arterial systolic pressure (s.a.p.) exceeding 30% of the initial (stage 1) value was found in five patients receiving metocurine compared with only one receiving pancuronium. Two minutes after the administration of metocurine in two patients s.a.p. was less than 85 mm Hg (70 and 75 mm Hg, respectively).
After tracheal intubation (stage 4) AP, HR, SVR and RPP increased in both groups. No significant differences between the changes within the two groups occurred (stage 4 as compared with stage 2). An increase in s.a.p. exceeding 30% of the initial (stage 1) value was found only in one patient, who had received metocurine. AP and HR of stage 4 shown in figure 1 are those obtained at the time of cardiac output measurement, after the commencement of automatic ventilation. However, most patients exhibited greater values of AP and HR at the time of tracheal intubation. At the time of greatest s.a.p., the mean increases in RPP from the initial (stage 1) values were 14.5% in the pancuronium group and 17.1% in the metocurine group. No difficulties were encountered in intubating the patients and no additional neuromuscular blocking drug was required during the later period of the study.
In stage 5 (before sternotomy) AP, CI, HR and RPP reached the smallest values. There were no significant differences between the changes within the two groups. A decrease in s.a.p. exceeding 30% of the initial value occurred in five patients of the pancuronium group and in eight of the metocurine group.
Surgical stimulation produced an increase in AP, HR, SVR and RPP, but there were no significant differences between the changes within the two groups (stage 6 compared with stage 2). One patient treated with pancuronium showed an increase in s.a.p. exceeding 30% of the initial value and three patients of the pancuronium group had RPP greater than 12 000 mm Hg beat mkr 1 , whereas the greatest individual RPP value in the metocurine group was 11 200 mm Hg beat min-1 . Significant depression (>0.1mV) of the ST segment (precordial lead) was found after intubation in one patient given metocurine and after sternotomy in two patients given pancuronium. No significant differences in blood-gas tensions or acid-base indices were found between the groups (table III) . Data for calculation of oxygen consumption were obtained in stages 1 and 5 of the study. In stage 5 oxygen consumption was decreased 24 ± 4 ml min" 1 m~2 in the pancuronium group and 34 ± 6 ml min" 1 m~2 in the metocurine group.
DISCUSSION

Design of the study
In most of the previous studies of the haemodynamic effects of metocurine, no comparison has been made with other neuromuscular blocking agents. Furthermore, haemodynamic measurements have generally been made during a steady state as suggested by Kennedy and Kelman (1970) . Therefore, we compared haemodynamic measurements after the administration of equipotent doses (Savarese, Ali and Antonio, 1977) of metocurine and pancuronium throughout the course of anaesthesia until surgery had started.
Although our patient groups were comparable in other respects, there were some differences in the initial haemodynamic values which decreased after the induction of anaesthesia. Therefore, we used the post-induction values as control when the haemodynamic effects of the neuromuscular blocking drugs were compared.
Metocurine
The changes found 5 min after the administration of metocurine differ from those reported by Zaidan and colleagues (1977) in patients with coronary artery disease. Their patients showed no decrease in AP or HR, whereas CO increased significantly. These effects may be a result of light anaesthesia (morphine 0.5 mg kg-1 and 50% nitrous oxide) or the smaller dose (0.35 mg kg" 1 ) and slower rate of injection of metocurine in Zaidan's study.
A small decrease in AP and no change in CI have been reported after metocurine in patients without cardiovascular disease receiving halothane (Stoelting, 1974) or enflurane (Stanley, 1978) . During thiopentone-nitrous oxide-i.v. analgesic anaesthesia, metocurine 0.2-0.3 mg kg" 1 did not produce significant changes in AP or HR (Hughes, Ingram and Payne, 1976; Savarese, Ali and Antonio, 1977) , whereas greater doses produced hypotension (Savarese, Ali and Antonio, 1977) . Hypotension has been attributed to histamine release and a slow injection rate is recommended when large doses of metocurine are given to patients with poorly compensated circulatory states (Savarese, Ali and Antonio, 1977) .
Like Zaidan and others (1977) and Stanley (1978) we observed a small decrease in SVR. Fogdall and DeMaster (1977) have presented evidence to suggest that metocurine may cause venodilatation. Since the filling pressures of the heart were decreased in our patients after metocurine, it is possible that a more rapid infusion of salt solution had partially prevented hypotension. The decreases in filling pressures were not, however, significantly greater after metocurine than after pancuronium.
Pancuronium
Several investigators have reported increases in HR, CO and AP after pancuronium during steadystate anaesthesia (Loh, 1970; Kelman and Kennedy, 1971; Stoelting, 1972; Miller et al., 1975) . These changes probably result from the vagolytic action of pancuronium at the cholinergic receptors in the heart (Saxena and Bonta, 1970; Hughes and Chappie, 1976) and they are prevented by atropine (Kelman and Kennedy, 1971; Miller et al., 1975) .
Although our patients did not receive atropine, they showed no increase in AP and HR after pancuronium. This finding accords with the results of several other studies in which pancuronium was given to patients about to undergo cardiac surgery (Harrison, 1972; Lyons and Clarke, 1972; Clarke and Lyons, 1977; Maunuksela, 1977) . In these studies, as in our own, pancuronium was given immediately after induction of anaesthesia. Therefore, it is probable that the measurements were not made during a steady state. Furthermore, the results may have been influenced by cardiac disease and residual effects of digoxin or beta-adrenergic blocking drugs. Whatever the cause of the absence of increase in HR and AP, it is still possible that the differences in HR, CI and AP at stage 3 between our pancuronium and metocurine groups are a result of the vagolytic effect of pancuronium.
Metocurine v. pancuronium Savarese, Ali and Antonio (1977) have suggested that metocurine may be the myoneural blocking drug of choice during the administration of anaesthesia to patients with coronary artery disease. In these patients increases in RPP or episodes of hypotension may precipitate myocardial ischaemia (Waller, Kaplan and Jones, 1979) . In our patients hypotension occurred more frequently after metocurine than after pancuronium (stage 3). Although this hypotension was not associated with ischaemic e.c.g. changes, it is potentially dangerous. In spite of the large doses of myoneural blocking drugs used, no attenuation was observed in circulatory response (RPP) to tracheal intubation in the metocurine group as compared with the pancuronium group. This finding seems to differ from that of Basta and Lichtiger (1977) , who compared the effects of metocurine and pancuronium on changes in the tension-time index (TTI) evoked by endotracheal intubation in patients with coronary artery disease and anaesthetized with halothanenitrous oxide. TTI after intubation was significantly greater in their pancuronium group and 18% of the patients given pancuronium showed ST segment depression.
During surgical stimulation, two patients in our pancuronium group developed significant ST segment depression in the precordial lead and RPP was greater in the pancuronium group than in the metocurine group, although the difference was not statistically significant. Further studies are needed to clarify the efficacy of metocurine in attenuating circulatory responses to various stimuli.
In patients with coronary artery disease a large bolus dose of metocurine offered no obvious advantage over pancuronium. After metocurine, hypotension occurred more frequently than after pancuronium and no' significant differences were found in circulatory responses to tracheal intubation or surgical stimulation between the metocurine and pancuronium groups. Our patients were under relatively deep anaesthesia achieved with diazepam, anileridine, thiopentone and nitrous oxide and we realize that the haemodynamics after the administration of a neuromuscular blocking drug depend greatly on the milieu into which the drug is administered. 
COMPARAISON DBS EFFETS
SUMAWO
Los efectos hemodinamicos de grandes dosi* de tipo bolus de metocurina (0,45 mg kg-1 ) y de pancuronium (0,1 mg kg-1 ) se compararon en pacicntes con enfermedadc* de la arteria coronaria, anestesiados con diazepam, anileridina y 6xido nitroso. La hipotensidn tuvo lugar con mis freciicncil despues de la metocurina y tuvo como resultado Una disminud6n de la resistenda sistemica vascular. Despues del pancuronium no hubo incremento alguno en la presidn arterial ni en el ritmo cardiaco, pero se presentd un pequefio incremento del indice cardiaco. La di«minMfi*6n del ritmo cardiaco despues de la metocurina fue la principal causa de la diferencia cstadlsticamente significative en el Indice cardiaco entre los dos grupos. En oposid6n a lot resultados previos, la metocurina no atenu6 la respuestas circulatorias a la intubaci6n traqueal. Durante la estimuladin quirurgica, dos de los diez padentes del grupo dc pancuronium desarrollaron una depresidn significative del tegmento ST y tres de los padentes presentaron una reladdn de ritmopresion superior a 12 000 mm Hg latidos min"
1 . No obstante, la diferencia entre la relacion de ritmo-presibn entre los grupos no fue de un significado ettadlsdco.
